Adil I. Khan, MSc, PhD, Medical Director of Point-of-Care Testing & Clinical Chemistry Laboratories at Temple University Health System and Associate Professor of Pathology & Laboratory Medicine at the Lewis Katz School of Medicine at Temple University, spoke with Healthcare-in-Europe.com about point-of-care testing (POCT). Dr. Khan described how POCT is a win-win for patients and health care professionals and where the industry, which is the fastest-growing in the diagnostic sector, is headed in the future.
Weather Alert: Temple Health remains open, though some appointments or services may be adjusted. Patients will be contacted directly if their visit is affected. Please check TempleHealth.org for updates and monitor myTempleHealth for changes to scheduled appointments.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH
Related News
HCPLive Article on 2025 Coverage of Ultra-Rare Kidney Disease C3 Glomerulopathy Includes Perspective from Dr. Jared Hassler
Posted January 9, 2026An HCPLive year-end article about 2025 coverage of C3 glomerulopathy, or C3G, included perspective from Jared R. Hassler, MD.
Read More